Skip to main content
65°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
29.42
-0.24 (-0.81%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
34
35
Next >
Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease
December 06, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day
December 01, 2022
From
Pfizer Inc.
Via
Business Wire
Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases
December 01, 2022
From
Roivant Sciences
Via
GlobeNewswire
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
November 30, 2022
Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Longwood Healthcare Leaders to Bring Together Several Hundred Top Biotech and Pharmaceutical Leaders on Jan. 5-6, 2023
November 30, 2022
Longwood Fund, an early-stage life science venture firm, will convene several hundred top biotech and pharmaceutical leaders at its Pre-JPM Longwood Healthcare Leaders meeting, hosted virtually via...
Via
Newswire.com
Exposures
Product Safety
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 28, 2022
From
Pfizer Inc.
Via
Business Wire
Nutraceutical Supplements Market to Witness Huge Growth : Glanbia, Pfizer, Bayer, DowDuPont
November 25, 2022
Understand focused approach and business strategies that competitors are keeping to reach target audience, Get one step closer to leaders and high growth emerging players of Nutraceutical Supplements...
Via
SBWire
Graphic design as a service Company Doozoo secures strategic investment partner, launches fresh branding and expands resource within USA to meet growing global demand.
November 22, 2022
Via
Get News
Arvinas Announces ARV-471 Achieves a Clinical Benefit Rate of 38% in Evaluable Patients and Continues to Show a Favorable Tolerability Profile in its Phase 2 Expansion Trial (VERITAC)
November 22, 2022
From
Arvinas Inc.
Via
GlobeNewswire
What the Latest Science Says About COVID-19 Testing and Treatment
November 17, 2022
Via
StatePoint Media
Topics
Death
Exposures
COVID-19
Death
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
November 16, 2022
EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Four Healthcare Stocks To Watch This Week
November 16, 2022
Healthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue.
Via
MarketBeat
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Glisser Agrees Strategic Partnership with American Express Global Business Travel
November 14, 2022
Via
Get News
Physicians for Informed Consent Challenges the Basis for COVID-19 Vaccine Mandates
November 11, 2022
According to Physicians for Informed Consent, new data raise serious concerns over the risks of hospitalization in people vaccinated with the COVID-19 vaccine.
Via
Newswire.com
Topics
Death
Exposures
COVID-19
Death
The Dr. Erik Goluboff Scholarship for Future Medical Doctors Available in the United States
November 11, 2022
Via
Get News
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 11, 2022
From
Pfizer Inc.
Via
Business Wire
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
November 10, 2022
Learn more about Organicell Regenerative Medicine, Inc.from this latest report.
Via
TheNewswire.com
Exposures
COVID-19
Product Safety
NYSE:PFE Investor Alert: Investigation over Possible Securities Laws Violations by Pfizer Inc.
November 10, 2022
San Diego, CA -- (SBWIRE) -- 11/10/2022 -- Pfizer Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Drug Repurposing Market to Eyewitness Huge Growth by 2027 : Allergan, Astellas Pharma, Biovista, NuMedii
November 07, 2022
Stay up-to-date with Drug Repurposing Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Exposures
Product Safety
Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine
November 04, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
November 03, 2022
From
Pfizer Inc.
Via
Business Wire
PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK
November 01, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate
November 01, 2022
From
Pfizer Inc.
Via
Business Wire
Why Investors Are Suddenly Excited About Vaxcyte
October 31, 2022
Vaxcyte, Inc. is a small cap biotech company that catapulted back to mid-cap land with a stunning 110% surge — and may not be done yet.
Via
MarketBeat
Exposures
COVID-19
Author A. D. Stowers' New Book 'Michaela's Miracle' is a Stirring True Story of Loss, Heartache and Joy Centered Around a Young Woman Who Comes to Understand Love
October 28, 2022
Recent release 'Michaela's Miracle' from Covenant Books author A. D. Stowers is an impactful tale based on true events that follow Michaela, who has only ever known rejection and abandonment her entire...
Via
Newswire.com
Pfizer Stock Falls After a Tax Investigation Is Launched Against the Company in Italy
October 27, 2022
Pfizer Stock (NYSE:PFE) According to a story published on Thursday by Reuters, which cited two individuals with knowledge of the situation, the tax authorities in Italy are probing the earnings...
Via
PressReach
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Pfizer Inc. (PFE) on Behalf of Investors
October 27, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Pfizer Inc. and Encourages Investors with Losses to Contact the Firm
October 27, 2022
From
The Schall Law Firm
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Pfizer Inc. (PFE) on Behalf of Investors
October 27, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
34
35
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.